Thomas J. Schall, President and CEO at ChemoCentryx, Inc. (CCXI), sold 82,873 shares at $11.00 ($914K) on 2018-05-01, disclosed to the SEC on 2018-05-03.
Open-market sale of $914k CCXI by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.00 | 17,127 | $188K | 20.6% |
| 2 | $11.03 | 32,873 | $363K | 39.7% |
| 3 | $11.03 | 32,873 | $363K | 39.7% |
| Total | $11.02 avg | 82,873 | $914K | 100% |
| Filing → |
| IMRX | BUY | 2025-06-18 | $179K | — | Filing → |
| IMRX | BUY | 2024-03-25 | $7K | — | Filing → |
| CCXI | SELL | 2022-08-08 | $6.5M | — | Filing → |